Top

Quality of Life Research

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in:

01-03-2009 | Brief Communication

Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D

Auteurs: A. Szende, N. K. Leidy, E. Ståhl, K. Svensson

Gepubliceerd in: Quality of Life Research | Uitgave 2/2009

Abstract

Objective

The objective of this study was to understand systematic differences in utility values derived from the EQ-5D and the SF-6D in two respiratory populations with heterogeneous disease severity.

Methods

This study involved secondary analysis of data from two cross-sectional surveys of patients with asthma (N = 228; Hungary) and COPD (N = 176; Sweden). Disease severity was defined according to GINA and GOLD guidelines for asthma and COPD, respectively. EQ-5D and SF-6D scores and their distributional characteristics were compared across the two samples by disease severity level.

Results

Within each patient population, mean EQ-5D and SF-6D scores were similar for the overall group and for those with moderate disease. Mean scores varied for patients with mild and severe disease. EQ-5D versus SF-6D scores in the asthma group by severity levels were 0.89 versus 0.80, 0.70 versus 0.73, 0.63 versus 0.64, and 0.51 versus 0.63, respectively. EQ-5D versus SF-6D scores in the COPD group by severity levels were 0.85 versus 0.80, 0.73 versus 0.73, 0.74 versus 0.73, and 0.53 versus 0.62, respectively.

Conclusions

Results suggest the EQ-5D and SF-6D do not yield consistent utility values in patients with asthma and COPD due to differences in underlying valuation techniques and the EQ-5D’s limited response options relative to mild disease.

vorige artikel The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis

Hawthorne, G., Richardson, J., & Day, N. A. (2001). A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Annals of Medicine, 33(5), 358–370. doi: 10.3109/07853890109002090. PubMedCrossRef

Kopec, J. A., & Willison, K. D. (2003). A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology, 56(4), 317–325. doi: 10.1016/S0895-4356(02)00609-1. PubMedCrossRef

The EuroQoL Group. (1990). EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam), 16, 199–208. doi: 10.1016/0168-8510(90)90421-9.

Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292. doi: 10.1016/S0167-6296(01)00130-8. PubMedCrossRef

WHO Strategy for prevention and control of Chronic Respiratory Diseases. www.who.int.

Szende, A., Svensson, K., Stahl, E., Meszaros, A., & Berta, G. Y. (2004). Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. PharmacoEconomics, 22(8), 537–547. doi: 10.2165/00019053-200422080-00005. PubMedCrossRef

Global initiative for asthma (GINA) guidelines. (1998). Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report.

Ståhl, E., Lindberg, A., Rönmark, E., Svensson, K., Jansson, S.-A., Andersson, F., et al. (2001). The level of health-related quality of life in patients with COPD and its dependence on age, gender, and disease severity. The European Respiratory Journal, 18(Suppl 33), 184s. doi: 10.1183/09031936.01.00084401.

Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R., Hurd, S. S., & The GOLD Scientific Committee. (2001). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine, 163(5), 1047–1048.

10.

Szende, A., Oppe, M., & Devlin, N. (Eds.), (2007). The European VAS value set. In EQ–5D value sets. Inventory, comparative review and user guide (pp. 83–85). Dordrecht: Springer.

11.

Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108. doi: 10.1097/00005650-199711000-00002. PubMedCrossRef

12.

Green, C., Brazier, J., & Deverill, M. (2000). A Review of health state valuation techniques. PharmacoEconomics, 17(2), 151. doi: 10.2165/00019053-200017020-00004. PubMedCrossRef

13.

Dolan, P., & Sutton, M. (1997). Mapping VAS scores onto TTO and SG utilities. Social Science and Medicine, 44, 1289–1297. doi: 10.1016/S0277-9536(96)00271-7.

14.

Johnson, J. A., & Pickard, A. S. (2000). Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Medical Care, 38(1), 115–121. doi: 10.1097/00005650-200001000-00013. PubMedCrossRef

15.

Badia, X., Schiaffino, A., Alonso, J., & Herdman, M. (1998). Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Quality of Life Research, 7(4), 311–322. doi: 10.1023/A:1008894502042. PubMedCrossRef

16.

Bharmal, M., & Thomas, J., III (2006). Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value in Health, 9(4), 262–271. doi: 10.1111/j.1524-4733.2006.00108.x. PubMedCrossRef

17.

Konig, H. H., Ulshofer, A., Gregor, M., von Tirpitz, C., Reinshagen, M., Adler, G., et al. (2002). Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology, 14(11), 1205–1215. doi: 10.1097/00042737-200211000-00008. PubMedCrossRef

18.

Wu, A. W., Jacobson, K. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., et al. (2002). Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11(3), 273–282. doi: 10.1023/A:1015240103565. PubMedCrossRef

19.

Conner-Spady, B., & Suarez-Almazor, M. E. (2003). Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Medical Care, 41(7), 791–801. doi: 10.1097/00005650-200307000-00003. PubMedCrossRef

20.

Marra, C. A., Esdaile, J. M., Guh, D., Kopec, J. A., Brazier, J. E., Koehler, B. E., et al. (2004). A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Medical Care, 42(11), 1125–1131. doi: 10.1097/00005650-200411000-00012. PubMedCrossRef

21.

Sach, T. H., Barton, G. R., Doherty, M., Muir, K. R., Jenkinson, C., & Avery, A. J. (2007). The relationship between body mass index and health-related quality of life: Comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity (London), 31(1), 189–196. doi: 10.1038/sj.ijo.0803365. CrossRef

22.

Barton, G. R., Sach, T. H., Doherty, M., Avery, A.J., Jenkinson, C., & Muir K. R. (2007). An assessment of the discriminative ability of the EQ-5D (index), SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. The European Journal of Health Economics Jun 29 [Epub ahead of print].

23.

Franks, P., Hanmer, J., & Fryback, D. G. (2006). Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample toward consistency in cost-effectiveness analyses. Medical Care, 44(5), 478–485. doi: 10.1097/01.mlr.0000207464.61661.05. PubMedCrossRef

24.

van Stel, H. F., & Buskens, E. (2006). Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health and Quality of Life Outcomes, 4, 20. doi: 10.1186/1477-7525-4-20. PubMedCrossRef

25.

Boonen, A., van der Heijde, D., Landewe, R., van Tubergen, A., Mielants, H., Dougados, M., et al. (2007). How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Annals of the Rheumatic Diseases, 66(6), 771–777. doi: 10.1136/ard.2006.060384. PubMedCrossRef

26.

Wee, H. L., Machin, D., Loke, W. C., Li, S. C., Cheung, Y. B., Luo, N., et al. (2007). Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value in Health, 10(4), 256–265. doi: 10.1111/j.1524-4733.2007.00174.x. PubMedCrossRef

27.

Longworth, L., & Bryan, S. (2003). An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics, 12(12), 1061–1067. doi: 10.1002/hec.787. PubMedCrossRef

28.

Lamers, L. M., Bouwmans, C. A., van Straten, A., Donker, M. C., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236. doi: 10.1002/hec.1125. PubMedCrossRef

29.

Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884. doi: 10.1002/hec.866. PubMedCrossRef

30.

Bryan, S., & Longworth, L. (2005). Measuring health-related utility: why the disparity between EQ-5D and SF-6D? The European Journal of Health Economics, 6(3), 253–260. doi: 10.1007/s10198-005-0299-9. PubMedCrossRef

31.

Tsuchiya, A., Brazier, J., & Roberts, J. (2006). Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. Journal of Health Economics, 25(2), 334–346. doi: 10.1016/j.jhealeco.2005.09.003. PubMedCrossRef

32.

Ferreira, P. L., Ferreira, L. N., & Pereira, L. N. (2008). How consistent are utility values? Quality of Life Research, 17(7), 1031–1042. doi: 10.1007/s11136-008-9368-8. PubMedCrossRef

33.

Grieve, R., Grishchenko, M., & Cairns, J. (2008). SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. The European Journal of Health Economics. (Epub ahead of print).

Titel: Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D
Auteurs: A. Szende
N. K. Leidy
E. Ståhl
K. Svensson
Publicatiedatum: 01-03-2009
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 2/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-008-9429-z

Mijn bibliotheek

Shop

Tips voor Mijn BSL

Bohn Stafleu van Loghum

Tip

Swipe om te navigeren naar een ander artikel

Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D

Abstract

Objective

Methods

Results

Conclusions

Mijn bibliotheek

Shop

Tips voor Mijn BSL

Bohn Stafleu van Loghum

Tip

Swipe om te navigeren naar een ander artikel

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Objective

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2009

Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial

Mediators, moderators, and modulators of causal effects in clinical trials––Dynamically Modified Outcomes (DYNAMO) in health-related quality of life

Obesity and health related quality of life in the general adult population of the Canary Islands

Does age modify the relationship between morbidity severity and physical health in English and Dutch family practice populations?

Exploring household income as a predictor of psychological well-being among long-term colorectal cancer survivors

Work status, daily activities and quality of life among people with severe mental illness